Future applications of 3D bioprinting: A promising technology for treating recessive dystrophic epidermolysis bullosa-Reference-Cited by-同舟云学术

Future applications of 3D bioprinting: A promising technology for treating recessive dystrophic epidermolysis bullosa

Published:2021-11-07 Issue: Volume: Page:
ISSN:0906-6705
Container-title:Experimental Dermatology
language:en
Short-container-title:Exp Dermatol

Author:

Popp Courtney M.¹,Miller William C.¹,Eide Cindy R.¹,Tolar Jakub¹²^ORCID

Affiliation:

1. Department of Pediatrics Medical School University of Minnesota Minneapolis Minnesota USA

2. Stem Cell Institute University of Minnesota Minneapolis Minnesota USA

Publisher

Wiley

Subject

Dermatology,Molecular Biology,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/exd.14484

Reference76 articles.

1. An economic evaluation of the impact, cost, and medicare policy implications of chronic nonhealing wounds;Nussbaum SR;Value Health,2018

2. Epidemiology of burns throughout the world. Part I: distribution and risk factors;Peck MD;Burns,2011

3. Wound healing essentials: let there be oxygen;Sen CK;Wound Repair Regen,2009

4. SettipalliSA robust market rich with opportunities: Advanced wound dressings. PM360.https://www.pm360online.com/a‐robust‐market‐rich‐with‐opportunities‐advanced‐wound‐dressings/June ed. 2015. Accessed multiple times.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Commercial articulated collaborative in situ 3D bioprinter for skin wound healing;International Journal of Bioprinting;2023-01-31

2. A review on cell damage, viability, and functionality during 3D bioprinting;Military Medical Research;2022-12-16

3. A focused review on three-dimensional bioprinting technology for artificial organ fabrication;Biomaterials Science;2022